Lauren Theilen
( out of 24 reviews )

Lauren Theilen, MD, MS

Languages spoken: English, Spanish

Clinical Locations

University of Utah Hospital

University Maternal Fetal Medicine, Area E
Salt Lake City
801-213-2995
Directions

  • Dr. Lauren H. Theilen is a specialist in the management of high-risk pregnancies. She provides comprehensive prenatal care, consultations, and follow-up services through various stages of pregnancy and postpartum. She is currently accepting new patients. To schedule an appointment with Dr. Theilen, please call the women's health center at 801-213-2995.

    Her clinical and research interests focus on hypertensive disorders of pregnancy, the implications of pregnancy on future health, enhancing postpartum care and managing alloimmunization. She is actively involved in the University of Utah Virtual Prenatal Care Program, which offers personalized and convenient prenatal visits via telehealth. Additionally, Dr. Theilen contributes as an "e-consultant" through Project CORE, an initiative designed to broaden access to subspecialty care by providing e-consults to primary care and OB providers.

    Dr. Theilen earned her Bachelor of Arts in the Plan II Liberal Arts Honors Program from the University of Texas at Austin, followed by her Medical Doctorate from the University of Texas Health Science Center at San Antonio. She completed her residency in Obstetrics & Gynecology at Barnes-Jewish Hospital/Washington University in St. Louis, where she also served as Chief Resident. She then subspecialized by completing a fellowship in Maternal-Fetal Medicine and also earned an MSCI at the University of Utah. Dr. Theilen is board-certified in Obstetrics & Gynecology and holds a subspecialty certification in Maternal-Fetal Medicine from the American Board of Obstetrics & Gynecology.

    In her academic role as an assistant professor of obstetrics and gynecology, Dr. Theilen trains medical students, residents, and fellows at the University of Utah, sharing her knowledge and passion for Maternal-Fetal Medicine. Her approach to teaching and patient care emphasizes evidence-based practices and the importance of patient relationships.

    Dr. Theilen has earned funding from the NIH and other sponsors to support her research on optimizing postpartum maternal cardiovascular health after hypertensive disorders of pregnancy. She is working to develop patient-centered, effective interventions to promote health and wellness in the postpartum period and beyond for women who have experienced pregnancy complications.

    Specialties

    Board Certification

    American Board of Obstetrics & Gynecology (Obstetrics & Gynecology)
    American Board of Obstetrics & Gynecology (Sub: Maternal-Fetal Medicine)

    Patient Rating

    4.7 /5
    ( out of 24 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    October 29, 2024
    UH HOSPITALS AND CLINICS

    More concerned with standards

    April 29, 2024
    UH HOSPITALS AND CLINICS

    Dr. Thielen provided excellent, thorough, tailored counseling. She answered all my questions in great detail and was warm and empathetic.

    August 19, 2023
    EXTERNAL SITE

    Makes sure not only me as mom is safe and healthy but that your unborn child gets what they need as well!

    May 14, 2023
    UH HOSPITALS AND CLINICS

    Dr. Theilen is an amazing doctor who listens and makes you feel comfortable.

    March 19, 2023
    UH HOSPITALS AND CLINICS

    Dr. Theilen is a great listener and takes her time to give you the information you are asking for.

    January 30, 2023
    UH HOSPITALS AND CLINICS

    Dr. Theilen is an exceptional doctor and made me feel good about my future pregnancy's

  • Dr. Lauren H. Theilen is a specialist in the management of high-risk pregnancies. She provides comprehensive prenatal care, consultations, and follow-up services through various stages of pregnancy and postpartum. She is currently accepting new patients. To schedule an appointment with Dr. Theilen, please call the women's health center at 801-213-2995.

    Her clinical and research interests focus on hypertensive disorders of pregnancy, the implications of pregnancy on future health, enhancing postpartum care and managing alloimmunization. She is actively involved in the University of Utah Virtual Prenatal Care Program, which offers personalized and convenient prenatal visits via telehealth. Additionally, Dr. Theilen contributes as an "e-consultant" through Project CORE, an initiative designed to broaden access to subspecialty care by providing e-consults to primary care and OB providers.

    Dr. Theilen earned her Bachelor of Arts in the Plan II Liberal Arts Honors Program from the University of Texas at Austin, followed by her Medical Doctorate from the University of Texas Health Science Center at San Antonio. She completed her residency in Obstetrics & Gynecology at Barnes-Jewish Hospital/Washington University in St. Louis, where she also served as Chief Resident. She then subspecialized by completing a fellowship in Maternal-Fetal Medicine and also earned an MSCI at the University of Utah. Dr. Theilen is board-certified in Obstetrics & Gynecology and holds a subspecialty certification in Maternal-Fetal Medicine from the American Board of Obstetrics & Gynecology.

    In her academic role as an assistant professor of obstetrics and gynecology, Dr. Theilen trains medical students, residents, and fellows at the University of Utah, sharing her knowledge and passion for Maternal-Fetal Medicine. Her approach to teaching and patient care emphasizes evidence-based practices and the importance of patient relationships.

    Dr. Theilen has earned funding from the NIH and other sponsors to support her research on optimizing postpartum maternal cardiovascular health after hypertensive disorders of pregnancy. She is working to develop patient-centered, effective interventions to promote health and wellness in the postpartum period and beyond for women who have experienced pregnancy complications.

    Board Certification and Academic Information

    Academic Departments Obstetrics & Gynecology -Assistant Professor
    Academic Divisions Maternal Fetal Medicine
    Board Certification
    American Board of Obstetrics & Gynecology (Obstetrics & Gynecology)
    American Board of Obstetrics & Gynecology (Sub: Maternal-Fetal Medicine)

    Education history

    Fellowship Maternal-Fetal Medicine - University of Utah School of Medicine Clinical Fellow
    Graduate Training University of Utah School of Medicine M.S.C.I
    Chief Resident Obstetrics & Gynecology - Barnes-Jewish Hospital/Washington University in St. Louis Chief Resident
    Residency Obstetrics & Gynecology - Barnes-Jewish Hospital/Washington University in St. Louis Resident
    Professional Medical Medicine - University of Texas Health Science Center at San Antonio M.D.
    Undergraduate Plan II Liberal Arts Honors Program - University of Texas at Austin B.A.

    Selected Publications

    Journal Article

    1. Theilen LH, Varner MW, Esplin MS, Horne BD (2024). Cardiovascular morbidity and mortality following hypertensive disorders of pregnancy. Pregnancy Hypertens, 36, 101122. (Read full article)
    2. Orton M, Theilen L, Clark E, Baserga M, Lauer S, Ou Z, Presson AP, Dupont T, Katheria A, Singh Y, Chan B (2023). Thermoregulation-Focused Implementation of Delayed Cord Clamping among <34 Weeks' Gestational Age Neonates. Am J Perinatol. (Read full article)
    3. Theilen LH, Hammad I, Meeks H, Fraser A, Manuck TA, Varner MW, Smith KR (2023). Long-term maternal mortality risk following spontaneous preterm birth: A retrospective cohort study. BJOG, 130(12), 1483-1490. (Read full article)
    4. Khan SS, Petito LC, Huang X, Harrington K, McNeil RB, Bello NA, Bairey Merz CN, Miller EC, Ravi R, Scifres C, Catov JM, Pemberton VL, Varagic J, Zee PC, Yee LM, Ray M, Kim JK, Lane-Cordova AD, Lewey J, Theilen LH, Saade GR, Greenland P, Grobman WA, NICHD nuMoM2b and NHLBI nuMoM2b Heart Health Study Networks (2023). Body Mass Index, Adverse Pregnancy Outcomes, and Cardiovascular Disease Risk. Circ Res, 133(9), 725-735. (Read full article)
    5. Schliep KC, Shaaban CE, Meeks H, Fraser A, Smith KR, Majersik JJ, Foster NL, Wactawski-Wende J, stbye T, Tschanz J, Padbury JF, Sharma S, Zhang Y, Facelli JC, Abdelrahman CS, Theilen L, Varner MW (2023). Hypertensive disorders of pregnancy and subsequent risk of Alzheimer's disease and other dementias. Alzheimers Dement (Amst), 15(2), e12443. (Read full article)
    6. Workalemahu T, Page JM, Meeks H, Yu Z, Guinto E, Fraser A, Varner MW, Theilen LH, Quinlan A, Coon H, Enquobahrie DA, Ananth CV, Tekola-Ayele F, Jorde LB, Silver RM (2022). Familial aggregation of stillbirth: A pedigree analysis of a matched case-control study. BJOG, 130(5), 454-462. (Read full article)
    7. Bruno AM, Allshouse AA, Metz TD, Theilen LH (2023). Hypertensive disorders of pregnancy pre- and postaspirin guideline publication in individuals with pregestational diabetes mellitus. Am J Obstet Gynecol MFM, 5(4), 100877. (Read full article)
    8. Theilen LH, Greenland P, Varagic J, Catov J, Shanks A, Thorsten V, Parker CB, McNeil R, Mercer B, Hoffman M, Wapner R, Haas D, Simhan H, Grobman W, Chung JH, Levine LD, Barnes S, Bairey Merz N, Saade G, Silver RM (2022). Association between aspirin use during pregnancy and cardiovascular risk factors 2-7 years after delivery: The nuMoM2b Heart Health Study. Pregnancy Hypertens, 28, 28-34. (Read full article)
    9. Theilen LH, Greenland P, Varagic J, Catov J, Shanks A, Thorsten V, Parker CB, McNeil R, Mercer B, Hoffman M, Wapner R, Haas D, Simhan H, Grobman W, Chung JH, Levine LD, Barnes S, Bairey Merz N, Saade G, Silver RM (2022). Association between aspirin use during pregnancy and cardiovascular risk factors 2-7 years after delivery: The nuMoM2b Heart Health Study. Pregnancy Hypertens, 28(4), 28-34. (Read full article)
    10. Theilen LH, McNeil RB, Hunter S, Grobman WA, Parker CB, Catov JM, Pemberton VL, Ehrenthal DB, Haas DM, Hoffman MK, Chung JH, Mukhtar F, Arzumanyan Z, Mercer B, Parry S, Saade GR, Simhan HN, Wapner RJ, Silver RM, NHLBI nuMoM2b Heart Health Study Network (2021). Serum Cotinine and Adverse Cardiovascular Outcomes: A Cross-sectional Secondary Analysis of the nuMoM2b Heart Health Study. Am J Perinatol. (Read full article)
    11. de Havenon A, Delic A, Stulberg E, Sheibani N, Stoddard G, Hanson H, Theilen L (2021). Association of Preeclampsia With Incident Stroke in Later Life Among Women in the Framingham Heart Study. JAMA Netw Open, 4(4), e215077. (Read full article)
    12. Theilen LH, Campbell HD, Mumford SL, Purdue-Smithe AC, Sjaarda LA, Perkins NJ, Radoc JG, Silver RM, Schisterman EF (2020). Platelet activation and placenta-mediated adverse pregnancy outcomes: an ancillary study to the Effects of Aspirin in Gestation and Reproduction trial. Am J Obstet Gynecol, 223(5), 741.e1-741.e12. (Read full article)
    13. Theilen LH (2020). Pregnancy as a window to future health: what next? BJOG, 127(12), 1498. (Read full article)
    14. Bushman ET, Theilen LH, Monson M, Hammad I, Esplin I, Esplin MS (2019). Effect of blood contamination on amniotic fluid detection in vitro using immunoassays. J Matern Fetal Neonatal Med, 33(17), 2909-2912. (Read full article)
    15. Sean Esplin M, Hoffman MK, Theilen L, Kupchak P (2019). Prospective evaluation of the efficacy of immunoassays in the diagnosis of rupture of the membranes. J Matern Fetal Neonatal Med, 33(15), 2594-2600. (Read full article)
    16. Hammad IA, Meeks H, Fraser A, Theilen LH, Esplin MS, Smith KR, Varner MW (2019). Risks of cause-specific mortality in offspring of pregnancies complicated by hypertensive disease of pregnancy. Am J Obstet Gynecol, 222(1), 75.e1-75.e9. (Read full article)
    17. Haas DM, Parker CB, Marsh DJ, Grobman WA, Ehrenthal DB, Greenland P, Bairey Merz CN, Pemberton VL, Silver RM, Barnes S, McNeil RB, Cleary K, Reddy UM, Chung JH, Parry S, Theilen LH, Blumenthal EA, Levine LD, Mercer BM, Simhan H, Polito L, Wapner RJ, Catov J, Chen I, Saade GR, NHLBI nuMoM2b Heart Health Study (2019). Association of Adverse Pregnancy Outcomes With Hypertension 2 to 7 Years Postpartum. J Am Heart Assoc, 8(19), e013092. (Read full article)
    18. Curtin K, Theilen LH, Fraser A, Smith KR, Varner MW, Hageman GS (2019). Hypertensive disorders of pregnancy increase the risk of developing neovascular age-related macular degeneration in later life. Hypertens Pregnancy, 38(3), 141-148. (Read full article)
    19. Theilen LH (2018). Pre-eclampsia and cardiovascular risk: comparing apples with apples. BJOG, 125(13), 1655. (Read full article)
    20. Theilen LH, Meeks H, Fraser A, Esplin MS, Smith KR, Varner MW (2018). Long-term mortality risk and life expectancy following recurrent hypertensive disease of pregnancy. Am J Obstet Gynecol, 219(1), 107.e1-107.e6. (Read full article)
    21. Heuser CC, Gibbins KJ, Herrera CA, Theilen LH, Holmgren CM (2018). Moms in medicine: Job satisfaction among physician-mothers in obstetrics and gynecology. Work, 60(2), 201-207. (Read full article)
    22. Theilen LH, Mellnick VM, Shanks AL, Tuuli MG, Odibo AO, Macones GA, Cahill AG (2017). Acute Appendicitis in Pregnancy: Predictive Clinical Factors and Pregnancy Outcomes. Am J Perinatol, 34(6), 523-528. (Read full article)
    23. Theilen LH, Fraser A, Hollingshaus MS, Schliep KC, Varner MW, Smith KR, Esplin MS (2016). All-Cause and Cause-Specific Mortality After Hypertensive Disease of Pregnancy. Obstet Gynecol, 128(2), 238-244. (Read full article)
    24. Theilen LH, Mellnick VM, Longman RE, Tuuli MG, Odibo AO, Macones GA, Cahill AG (2015). Utility of magnetic resonance imaging for suspected appendicitis in pregnant women. Am J Obstet Gynecol, 212(3), 345.e1-6. (Read full article)
    25. Macones GA, Carter E, Theilen L, Fjeldstad H (2013). Expectant management of severe preeclampsia: Vigil-De Gracia et al. Am J Obstet Gynecol, 209(5), 493-4. (Read full article)
    26. McNeil JD, Propper B, Walker J, Holguin L, Evans L, Lee K, Fox PT, Michalek JE, Baisden CE (2011). A bovine hemoglobin-based oxygen carrier as pump prime for cardiopulmonary bypass: reduced systemic lactic acidosis and improved cerebral oxygen metabolism during low flow in a porcine model. J Thorac Cardiovasc Surg, 142(2), 411-7. (Read full article)

    Review

    1. Schliep KC, Mclean H, Yan B, Qeadan F, Theilen LH, de Havenon A, Majersik JJ, stbye T, Sharma S, Varner MW (2022). Association Between Hypertensive Disorders of Pregnancy and Dementia: a Systematic Review and Meta-Analysis. [Review]. Hypertension, 80(2), 257-267. (Read full article)

    Book Chapter

    1. Forrest AD, Hunt JT, Lamale-Smith L, Theilen LH (2024). Complicated Pregnancy and Delivery. In Hurt KJ (Ed.), Pocket Obstetrics & Gynecology (3rd). Wolters-Kluwer.
    2. Theilen LH, Adesomo AA, Varner MW (2024). Pregnancy as a Window to Future Maternal and Child Health. In Landon MB, Galan HL, Jauniaux ERM et al (Eds.), Gabbe's Obstetrics: Normal and Problem Pregnancies (9th). Elsevier.
    3. Theilen LH, Varner MW (2020). Pregnancy as a window to maternal and child health. In Gabbe's Obstetrics: Normal and Problem Pregnancies (8). Elsevier.

    Letter

    1. Bruno AM, Allshouse AA, Metz TD, Theilen LH (2022). Trends in Hypertensive Disorders of Pregnancy in the United States From 1989 to 2020. [Letter to the editor]. Obstet Gynecol, 140(1), 83-86. (Read full article)
    2. Bruno AM, Allshouse AA, Metz TD, Theilen LH (2022). Trends in Hypertensive Disorders of Pregnancy in the United States From 1989 to 2020. [Letter to the editor]. Obstet Gynecol, 140(1), 83-86. (Read full article)

  • News & Podcasts

    News

    Podcasts